Medizinische Universität Graz - Research portal
Martinez Serrat Maria |
** = Publications listed in SCI/SSCI/Pubmed
2025
Full paper/article (Journal)
** Damulina, A; Opriessnig, P; Pirpamer, L; Demjaha, R; Tafrali, C; Martinez-Serrat, M; Hofer, E; Wurth, S; Heschl, B; Hochmeister, S; Archelos, JJ; Pinter, D; Ropele, S; Enzinger, C; Khalil, M
Association of CSF Kappa-Free Light Chains With Cortical and Periventricular Brain Damage in Multiple Sclerosis.
Neurology. 2025; 105(12): e214433
Doi: 10.1212/WNL.0000000000214433
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Dargvainiene, J; Torge, A; Wandinger, KP; Junker, R; Markewitz, R; Benkert, P; Willemse, E; Maleska, A; Schuster, SO; Ziemann, M; Tafrali, C; Martinez-Serrat, M; Khalil, M; Kuhle, J; Leypoldt, F
Comparative analysis of three platforms for serum NfL quantification in healthy controls and MS patients.
Clin Chem Lab Med. 2025;
Doi: 10.1515/cclm-2025-1476
Web of Science
PubMed
FullText
FullText_MUG
** Rossini, F; Moser, T; Unterhofer, M; Khalil, M; Demjaha, R; Tafrali, C; Martinez-Serrat, M; Kuhle, J; Leppert, D; Benkert, P; Pfaff, JAR; Trinka, E; Pikija, S
Transient Global Amnesia (TGA): Is It Really Benign? A Pilot Study on Blood Biomarkers.
Int J Mol Sci. 2025; 26(6):
Doi: 10.3390/ijms26062629
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Datta, G; Martinez-Serrat, M; Tafrali, C; Demjaha, R; Pinter, D; Heschl, B; Damulina, A; Hofer, E; Ropele, S; Enzinger, C; McCurdy, S; Ruiz, L; Sheng, E; Hari, A; Tiwari, S; Hu, W; Brazel, D; Qureshi, F; Khalil, M
Characterizing MSDA Score and MSDA Panel Biomarker Associations with Disease Activity and Progression Measures in the Graz MS Study
MULT SCLER J. 2025; 31(3):326-326.-ECTRIMS 2025; SEP 24-26, 2025; Barcelona, SPAIN.
[Poster]
Web of Science
** Ellmeier, E; Schnabl, A; Meissel, J; Stracke, A; Rittchen, S; Stöger, L; Tafrali, C; Demjaha, R; Martinez-Serrat, M; Kaiser, T; Zeiler, LC; Seifried, K; Topler, A; Klemen, I; Heschl, B; Damulina, A; Runtsch, MC; Fessler, J; Hofer, E; Khalil, M; Angiari, S
Targeting pyruvate kinase M2 (PKM2) reduces T cell pathogenicity in multiple sclerosis
MULT SCLER J. 2025; 31(3): 971-971.
Web of Science
** Hegen, H; Föttinger, F; Walde, J; Berek, K; Martinez-Serrat, M; Damulina, A; Krajnc, N; Ponleitner, M; Di Pauli, F; Enzinger, C; Deisenhammer, F; Berger, T; Khalil, M; Bsteh, G
The role of age in choosing high-efficacy treatment for multiple sclerosis - an Austrian MS Database study
MULT SCLER J. 2025; 31(3): 394-395.
Web of Science
** Helmlinger, B; Hechenberger, S; Jordan, S; Marschik, P; Trafali, C; Martinez-Serrat, M; Demjaha, R; Wurth, S; Damulina, A; Heschl, B; Khalil, M; Enzinger, C; Pinter, D
Motor Fatigue in Multiple Sclerosis: The Distinct Role of Motor and Psychological Factors
MULT SCLER J. 2025; 31(3): 827-828.
[Poster]
Web of Science
** Liutkevych, K; Helmlinger, B; Hechenberger, S; Jordan, S; Heschl, B; Damulina, A; Demjaha, R; Tafrali, C; Martinez-Serrat, M; Khalil, M; Enzinger, C; Pinter, D
Factors associated with fatigue and fatigue worsening in multiple sclerosis
MULT SCLER J. 2025; 31(3): 164-165.
[Poster]
Web of Science
** Mart nez-Serrat, M; Tafrali, C; Demjaha, R; Kaiser, T; Hofer, E; Ropele, S; Heschl, B; Wurth, S; Damulina, A; Pinter, D; Leppert, D; Benkert, P; Kuhle, J
Temporal dynamics of serum neurofilament light chain in MS: A retrospective study in a clinical routine setting
EUR J NEUROL. 2025; 32:
[Oral Communication]
Web of Science
** Martinez-Serrat, M; Datta, G; Tafrali, C; Demjaha, R; Helmlinger, B; Kaiser, T; Pinter, D; Heschl, B; Damulina, A; Hofer, E; Ropele, S; Enzinger, C; Brazel, D; Qureshi, F; Khalil, M
Temporal Dynamics of Proteomic Profiling in Multiple Sclerosis: Insights from a Retrospective Longitudinal Study
MULT SCLER J. 2025; 31(3): 306-307.
Web of Science
** Martinez-Serrat, M; Tafrali, C; Demjaha, R; Helmlinger, B; Kaiser, T; Hofer, E; Ropele, S; Heschl, B; Damulina, A; Leppert, D; Benkert, P; Kuhle, J; Enzinger, C; Khalil, M
Assessing the Role of Glial Fibrillary Acidic Protein in Combination with Neurofilament Light Chain for Multiple Sclerosis Disease Activity
MULT SCLER J. 2025; 31(3): 325-325.
[Poster]
Web of Science
** Martinez-Serrat, M; Tafrali, C; Demjaha, R; Helmlinger, B; Kaiser, T; Hofer, E; Ropele, S; Heschl, B; Damulina, A; Platos, E; Pinter, D; Leppert, D; Benkert, P; Kuhle, J; Enzinger, C; Khalil, M
Temporal Dynamics of Serum Neurofilament Light Chain in Multiple Sclerosis: A Retrospective Study in a Clinical Routine Setting
MULT SCLER J. 2025; 31(3): 310-311.
Web of Science
** Merseli, A; Haindl, MT; Hofer, E; Demjaha, R; Tafrali, C; Martinez-Serrat, M; Vittinghoff, K; Pinter, D; Enzinger, C; Lass, A; Khalil, M
The Implication of the Blood-Brain Barrier integrity on serum Neurofilament Light Chain levels as a marker for neuro-axonal injury
MULT SCLER J. 2025; 31(3): 763-764.
Web of Science
** Pinter, D; Jordan, S; Helmlinger, B; Hechenberger, S; Heschl, B; Damulina, A; Wurth, S; Demjaha, R; Tafrali, C; Martinez-Serrat, M; Khalil, M; Enzinger, C
Current versus chronic fatigue in people with multiple sclerosis and healthy controls - impact of cognition, sleep, anxiety and depression
MULT SCLER J. 2025; 31(3): 852-853.
[Poster]
Web of Science
** Tafrali, C; Martinez-Serrat, M; Demjaha, R; Buchmann, A; Hechenberger, S; Helmlinger, B; Opriessnig, P; Pinter, D; Damulina, A; Wurth, S; Heschl, B; Leppert, D; Benkert, P; Kuhle, J; Ropele, S; Enzinger, C; Khalil, M
Choroid plexus volume and serum neurofilament light levels in relation to brain atrophy and lesion load in MS
EUR J NEUROL. 2025; 32:
Web of Science